GO:1903393 positive regulation of adherens junction organization: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903393 describes any process that activates or increases the frequency, rate or extent of adherens junction organization, a key step in epithelial and endothelial barrier formation.
• Adherens junctions are cadherin-based cell-cell adhesion complexes whose assembly is tightly coupled to the actin cytoskeleton and cortical tension.
• Positive regulation of adherens junction organization is essential for tissue morphogenesis, barrier function, and is frequently dysregulated in cancer and inflammatory disease.
• Leukocyte transmigration across epithelial and endothelial monolayers transiently modulates adherens junction organization and paracellular permeability.
• Transcriptomic and bioinformatics studies have identified adherens junction-related genes and circRNAs as markers of tissue development and disease progression.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate regulators of adherens junction organization in relevant cell types.
Description
Adherens junctions are cadherin-containing cell-cell adhesion structures that mechanically link neighboring cells to the actin cytoskeleton and are central to tissue architecture, barrier function, and morphogenesis. The Gene Ontology term GO:1903393, positive regulation of adherens junction organization, captures the regulatory inputs that increase the assembly, maintenance, or remodeling of these junctions. Understanding this process is important because adherens junction dynamics underlie epithelial and endothelial barrier integrity, leukocyte transmigration, and developmental programs such as skeletal muscle formation. Dysregulation of adherens junction organization has been linked to cancer progression, inflammatory conditions, and developmental abnormalities, making its positive regulators attractive targets for mechanistic and translational research. Recent studies using transcriptomics, non-targeted metabolomics, and bioinformatics have begun to map the gene networks and non-coding RNAs that influence adherens junction-related processes in embryonic development and disease. This article synthesizes the current understanding of GO:1903393, its core molecular players, and the experimental approaches used to study it.
positive regulation of adherens junction organization At A Glance
| GO ID | GO:1903393 |
|---|---|
| GO term | positive regulation of adherens junction organization |
| Ontology | biological_process |
| Synonym | activation of adherens junction organization; upregulation of adherens junction assembly and maintenance |
| Major function | Increases the assembly, maintenance, and remodeling of cadherin-based adherens junctions |
| Related cellular component | Adherens junction, actin cytoskeleton, plasma membrane |
| Related molecular functions | Cadherin binding, actin filament binding, GTPase activity |
| Associated processes | Epithelial barrier formation, leukocyte transmigration, tissue morphogenesis |
What Is GO:1903393?
GO:1903393 is defined as any biological process that activates or increases the frequency, rate, or extent of adherens junction organization. In other words, it encompasses the signaling events, protein interactions, and cytoskeletal rearrangements that promote the proper assembly, stability, and remodeling of cadherin-based cell-cell adhesion complexes.
Why Is positive regulation of adherens junction organization Important in Cell Biology?
Positive regulation of adherens junction organization is fundamental to tissue homeostasis because it controls the strength and dynamics of cell-cell adhesion, which in turn governs barrier function, cell migration, and tissue morphogenesis. Dysregulation of this process contributes to cancer progression, where loss of adherens junction integrity promotes invasion and metastasis, and to inflammatory diseases characterized by increased paracellular permeability. Understanding the positive regulators of adherens junction organization therefore has broad implications for developmental biology, cancer research, and regenerative medicine.
• Maintains epithelial and endothelial barrier integrity by promoting cadherin-mediated cell-cell adhesion.
• Supports tissue morphogenesis during embryonic development, including skeletal muscle formation.
• Regulates leukocyte transmigration across endothelial and epithelial layers by modulating junctional dynamics.
• Its dysregulation is associated with cancer progression and metastasis.
• Influences paracellular permeability in inflammatory and infectious diseases.
• Provides a mechanistic link between cortical tension and cadherin-actin feedback loops.
• Serves as a target for bioinformatics and transcriptomic studies identifying disease biomarkers.
• Enables CRISPR-based functional studies of junctional regulators in diverse cell models.
What Happens During positive regulation of adherens junction organization?
Initiation by cadherin engagement and cortical tension
In simple terms: When cells touch, adhesion molecules called cadherins stick together and pull on the cell's internal skeleton, starting a positive feedback loop.
Positive regulation of adherens junction organization begins with the engagement of cadherin ectodomains between neighboring cells, which triggers a local increase in cortical tension and initiates a positive feedback loop between cadherin and F-actin. This mechanical coupling recruits actin-binding proteins and stabilizes the nascent junction, thereby increasing the rate and extent of adherens junction assembly.
Actin cytoskeleton remodeling and junctional stabilization
In simple terms: The cell's internal scaffold reorganizes to anchor the adhesion sites, making them stronger.
Following initial cadherin engagement, the actin cytoskeleton undergoes remodeling that reinforces the junctional complex. Cortical tension generated by actomyosin contractility promotes the clustering and stabilization of cadherin molecules, which in turn recruits additional F-actin and junctional proteins, further enhancing adherens junction organization. This positive feedback ensures robust and dynamic control of cell-cell adhesion.
Modulation by leukocytes and paracellular permeability
In simple terms: Immune cells can temporarily loosen the junctions between barrier cells to squeeze through, which involves regulated changes in junction organization.
Leukocyte interactions with epithelial and endothelial monolayers modulate adherens junction organization and paracellular permeability. During transmigration, leukocytes induce transient and reversible changes in junctional complexes, including adherens junctions, to allow passage while preserving barrier integrity. Positive regulation of adherens junction organization is therefore critical for restoring junctional integrity after leukocyte passage.
Transcriptional and non-coding RNA control
In simple terms: Genes and regulatory RNAs can turn the junction-building process up or down.
Transcriptomic profiling has identified numerous genes and circular RNAs associated with adherens junction organization during skeletal muscle development in chicken and duck embryos. Bioinformatics analyses of breast cancer datasets have also highlighted adherens junction-related pathways as potential mechanisms of action for therapeutic compounds. These studies suggest that positive regulation of adherens junction organization is subject to transcriptional and post-transcriptional control.
Key Genes Involved in GO:1903393 positive regulation of adherens junction organization
The following genes and proteins are experimentally or computationally implicated in positive regulation of adherens junction organization, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDH1 | Encodes E-cadherin, the core transmembrane adhesion protein of adherens junctions | Central to epithelial barrier function and cancer progression |
| CTNNB1 | Encodes beta-catenin, which links cadherins to the actin cytoskeleton | Key mediator of junctional signaling and transcriptional regulation |
| ACTB | Beta-actin, a major component of the actin cytoskeleton at adherens junctions | Essential for junctional stability and cortical tension |
| ACTN1 | Alpha-actinin-1, an actin-crosslinking protein enriched at adherens junctions | Modulates junctional actin dynamics |
| VCL | Vinculin, a mechanosensitive adaptor that reinforces cadherin-actin linkages | Important for tension-dependent junction stabilization |
| CTNNA1 | Alpha-catenin, which binds cadherins and actin filaments | Critical for adherens junction assembly and mechanotransduction |
| RAC1 | Rho-family GTPase that promotes actin polymerization at junctions | Regulates junction formation and remodeling |
| RHOA | Rho-family GTPase that controls actomyosin contractility | Modulates cortical tension and junctional stability |
| CDH5 | VE-cadherin, the endothelial-specific adherens junction protein | Essential for endothelial barrier function and leukocyte transmigration |
| JUP | Plakoglobin, a catenin family member that associates with cadherins | Contributes to junctional complex stability |
| ARPC2 | Component of the Arp2/3 complex that nucleates actin branches | Involved in junctional actin remodeling |
| DIAPH1 | Formin that nucleates linear actin filaments | Supports junctional actin architecture |
| MYH9 | Non-muscle myosin heavy chain IIA, generates contractile force | Regulates cortical tension at adherens junctions |
| PXN | Paxillin, a focal adhesion-associated protein also found at junctions | Potential crosstalk between adhesion systems |
| TJP1 | Zonula occludens-1, a tight junction protein that interacts with adherens junctions | Links tight and adherens junction organization |
| CDH2 | N-cadherin, a cadherin family member in non-epithelial tissues | Relevant to mesenchymal and neural junction organization |
| CTNND1 | p120-catenin, which stabilizes cadherins at the membrane | Modulates cadherin turnover and junction stability |
How Is positive regulation of adherens junction organization Regulated?
Positive regulation of adherens junction organization is controlled by mechanical and biochemical signals. Cortical tension generated by actomyosin contractility initiates a positive feedback loop that reinforces cadherin clustering and F-actin assembly. Rho-family GTPases, including RAC1 and RHOA, coordinate actin polymerization and contractility at junctions. Leukocyte-derived signals can transiently modulate junctional organization to facilitate transmigration, indicating that external cues regulate this process. Transcriptional and post-transcriptional mechanisms, including circular RNAs, have also been implicated in developmental contexts.
positive regulation of adherens junction organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDH1 | Breast cancer, gastric cancer, epithelial barrier dysfunction | CRISPR knockout in MCF-7 or MCF-10A cells |
| CTNNB1 | Colorectal cancer, hepatocellular carcinoma | Point mutation knock-in in HCT116 or HepG2 cells |
| CDH5 | Vascular permeability disorders, inflammation | Endothelial cell knockout in HUVECs |
| RAC1 | Cancer invasion, immune cell migration | Overexpression or knockout in epithelial and endothelial cells |
| MYH9 | Cytoskeletal disorders, hearing loss | Point mutation knock-in in fibroblast or epithelial cells |
Cancer progression and metastasis
Loss of adherens junction integrity is a hallmark of epithelial-mesenchymal transition and cancer progression. Bioinformatics analyses of breast cancer datasets have identified adherens junction organization as a pathway affected by potential therapeutic compounds, suggesting that positive regulators of this process may suppress invasive behavior. E-cadherin (CDH1) and beta-catenin (CTNNB1) are frequently dysregulated in cancers, underscoring the clinical relevance of GO:1903393.
Inflammatory and barrier disorders
Leukocyte transmigration across epithelial and endothelial barriers requires transient modulation of adherens junctions, and excessive or dysregulated junctional opening contributes to increased paracellular permeability in inflammatory conditions. Positive regulation of adherens junction organization is therefore critical for restoring barrier function after inflammation.
Developmental abnormalities
Adherens junction organization is essential for embryonic development, including skeletal muscle formation. Transcriptomic studies in chicken and duck embryos have identified circRNAs and genes associated with adherens junction pathways, suggesting that disruption of these regulatory networks could lead to developmental defects.
From positive regulation of adherens junction organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce adherens junction assembly? | CRISPR knockout in epithelial cells (e.g., MCF-10A) |
| Does a specific point mutation in CDH1 affect junction stability? | Point mutation knock-in in cancer cell lines |
| Can a tagged version of beta-catenin rescue junction defects? | Knock-in of tagged CTNNB1 in knockout background |
| Does overexpression of RAC1 enhance junction formation? | Overexpression in endothelial cells |
| How does cortical tension regulate cadherin clustering? | CRISPR knockout of MYH9 combined with live imaging |
| What circRNAs regulate adherens junction genes during development? | Overexpression or knockdown in chicken/duck embryonic models |
How to Study the positive regulation of adherens junction organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of adherens junction genes and circRNAs | Developmental and disease profiling |
| Bioinformatics pathway analysis | Enrichment of adherens junction organization pathways | Cancer and muscle development studies |
| Live-cell fluorescence microscopy | Cadherin clustering and F-actin dynamics | Mechanistic studies of junction assembly |
| Traction force microscopy | Cortical tension and mechanical forces at junctions | Feedback loop analysis |
| Transendothelial electrical resistance | Barrier integrity and paracellular permeability | Leukocyte transmigration assays |
| Paracellular flux assay | Permeability to tracer molecules | Inflammation and barrier studies |
| CRISPR knockout screening | Causal role of candidate genes in junction organization | Functional genomics |
| Proximity ligation assay | Protein-protein interactions at adherens junctions | Validation of junctional complexes |
Transcriptomic profiling
RNA sequencing and microarray analyses have been used to identify genes and non-coding RNAs associated with adherens junction organization during embryonic development and in disease models. These approaches reveal transcriptional networks that positively regulate junctional assembly.
Bioinformatics and pathway analysis
Integration of transcriptomics with non-targeted metabolomics and bioinformatics tools allows mapping of adherens junction-related pathways and identification of potential therapeutic targets. Such analyses have highlighted adherens junction organization as a key mechanism in breast cancer and skeletal muscle development.
Live-cell imaging and tension measurements
Fluorescence microscopy and traction force microscopy can visualize cadherin clustering, F-actin dynamics, and cortical tension at adherens junctions in real time. These methods directly assess the positive feedback between cadherin and actin.
Permeability assays
Measurement of transepithelial or transendothelial electrical resistance and paracellular flux is used to quantify barrier function, which reflects adherens junction organization. Such assays are valuable for studying leukocyte-induced changes in junctional permeability.
How CRISPR Can Be Used to Study GO:1903393 positive regulation of adherens junction organization
Knockout
CRISPR knockout of candidate genes such as CDH1, CTNNB1, or RAC1 in epithelial or endothelial cells can test whether they are required for positive regulation of adherens junction organization. Loss-of-function models reveal essential components and potential compensatory mechanisms.
Point Mutation
Introducing specific point mutations in genes like CDH1 or CTNNB1 allows researchers to dissect domain-specific functions and disease-associated variants without completely abolishing protein expression. Such models are valuable for studying mechanosensitive residues in cadherin or catenin proteins.
Knock-in
Knock-in of tagged versions of junctional proteins (e.g., GFP-tagged beta-catenin) enables live-cell imaging and biochemical isolation of adherens junction complexes. This approach helps track dynamic changes in junction organization under physiological and pathological conditions.
Overexpression
Overexpression of positive regulators such as RAC1 or VE-cadherin can enhance adherens junction assembly and barrier function, providing gain-of-function evidence for their role in GO:1903393. Overexpression models are also useful for testing whether increased junctional organization can rescue disease phenotypes.
How EDITGENE Supports positive regulation of adherens junction organization Research
Researchers studying positive regulation of adherens junction organization-related genes often need to determine whether a candidate gene is causally involved in junction assembly, maintenance, or remodeling. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of adherens junction organization research.
Frequently Asked Questions About positive regulation of adherens junction organization
What is GO:1903393?
GO:1903393 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of adherens junction organization.
What genes are involved in positive regulation of adherens junction organization?
Key genes include CDH1 (E-cadherin), CTNNB1 (beta-catenin), CDH5 (VE-cadherin), RAC1, RHOA, and actin cytoskeleton regulators such as ACTB and MYH9.
How is adherens junction organization regulated?
It is regulated by mechanical forces such as cortical tension, which initiates a positive feedback loop between cadherin and F-actin, as well as by Rho-family GTPases and transcriptional programs.
Why is positive regulation of adherens junction organization important in cancer?
Loss of adherens junction integrity promotes cancer invasion and metastasis, so positive regulators may suppress malignant progression.
What experimental models are used to study GO:1903393?
Common models include CRISPR knockout and knock-in cell lines, overexpression systems, live-cell imaging, and permeability assays in epithelial and endothelial cells.
How do leukocytes affect adherens junction organization?
Leukocytes transiently modulate adherens junctions to facilitate transmigration across endothelial and epithelial barriers, and positive regulation helps restore junctional integrity afterward.
What is the role of cortical tension in adherens junction organization?
Cortical tension initiates a positive feedback loop between cadherin and F-actin, reinforcing junction assembly and stability.
Which non-coding RNAs regulate adherens junction genes?
Circular RNAs have been implicated in the regulation of adherens junction-related genes during skeletal muscle development in chicken and duck embryos.
Can CRISPR be used to study positive regulation of adherens junction organization?
Yes, CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models enable causal testing of candidate regulators in relevant cell types.
What methods measure adherens junction organization?
Methods include live-cell imaging of cadherin and F-actin, transepithelial electrical resistance, paracellular flux assays, and transcriptomic profiling.
Conclusion
GO:1903393, positive regulation of adherens junction organization, is a critical biological process that governs cell-cell adhesion dynamics, barrier function, and tissue morphogenesis. Its dysregulation is linked to cancer, inflammation, and developmental disorders, making it a rich area for mechanistic and translational research. Advances in CRISPR-based models and multi-omics approaches continue to uncover the complex regulatory networks that control adherens junction assembly and maintenance.
References
- 1. Edens HA et al.. 2000. Modulation of epithelial and endothelial paracellular permeability by leukocytes.. Adv Drug Deliv Rev 41(3):315-28 PMID: 10854689
- 2. Yu Q et al.. 2022. Cortical tension initiates the positive feedback loop between cadherin and F-actin.. Biophys J 121(4):596-606 PMID: 35031276
- 3. Wu P et al.. 2022. Identification of crucial circRNAs in skeletal muscle during chicken embryonic development.. BMC Genomics 23(1):330 PMID: 35484498
- 4. Hu Z et al.. 2023. Integration of Transcriptomics and Non-Targeted Metabolomics Reveals the Underlying Mechanism of Skeletal Muscle Development in Duck during Embryonic Stage.. Int J Mol Sci 24(6) PMID: 36982289
- 5. Zhang Y et al.. 2019. The Potential Mechanism of Bufadienolide-Like Chemicals on Breast Cancer via Bioinformatics Analysis.. Cancers (Basel) 11(1) PMID: 30646630
- 6. Kong RS et al.. 2016. Transcriptome profiling of the rumen epithelium of beef cattle differing in residual feed intake.. BMC Genomics 17:592 PMID: 27506548
